Senate health care leaders have developed a bipartisan, fiscally responsible way to reduce the cost of the Medicare prescription drug benefit, also known as Medicare Part D. But pharmaceutical companies, in a furious lobbying effort, are trying to blow up the deal by demanding that taxpayers spend tens of billions on drug